ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $269,399,000 | -16.9% | 6,665 | +18.4% | 0.20% | -12.0% |
| Q2 2015 | $324,007,000 | +6.6% | 5,630 | +17.9% | 0.22% | +7.1% |
| Q1 2015 | $304,024,000 | +2.6% | 4,775 | -0.5% | 0.21% | +2.9% |
| Q4 2014 | $296,352,000 | +59.0% | 4,800 | 0.0% | 0.20% | +52.2% |
| Q3 2014 | $186,384,000 | +12.7% | 4,800 | 0.0% | 0.13% | +13.6% |
| Q2 2014 | $165,360,000 | -20.3% | 4,800 | 0.0% | 0.12% | -20.3% |
| Q1 2014 | $207,408,000 | +0.5% | 4,800 | -12.7% | 0.15% | -13.5% |
| Q3 2013 | $206,470,000 | – | 5,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 5,729,426 | $364,793,000 | 10.87% |
| DOWLING & YAHNKE LLC | 676,323 | $43,061,000 | 5.38% |
| WILLIAM HARRIS INVESTORS INC | 229,887 | $14,638,000 | 3.84% |
| Opus Point Partners Management, LLC | 60,912 | $3,878,000 | 3.25% |
| Nepsis Inc. | 64,580 | $4,112,000 | 2.48% |
| Private Capital Advisors, Inc. | 106,320 | $6,769,000 | 2.46% |
| PINNACLE ASSOCIATES LTD | 1,889,017 | $120,274,000 | 2.24% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 20,947 | $1,333,000 | 1.90% |
| Apex Capital Management | 928,654 | $59,127,000 | 1.39% |
| Bellevue Asset Management AG | 147,000 | $9,359,000 | 1.31% |